ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nosocomial Infection Treatment Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-37P5922
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Nosocomial Infection Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nosocomial Infection Treatment Market Research Report 2024

Code: QYRE-Auto-37P5922
Report
January 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Bayer
Becton Dickinson and Company
BELIMED
Biomerieux
Cantel
Cepheid Inc
Getinge Group
Kimberly Clark Corp
Merck
Nordion
Pfizer Inc
Roche
Sakura Seiki
bioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc
Advanced Sterilization Products
Matachana group

Nosocomial Infection Treatment Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Nosocomial Infection Treatment Market

Nosocomial Infection Treatment Market

Nosocomial infection, also known as hospital acquired or associated infection (HAI) is defined as an infection developed in patients during the hospital stay that was earlier not present or incubated during admission in the hospital.
The global Nosocomial Infection Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Nosocomial Infection Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nosocomial Infection Treatment.

Report Scope

The Nosocomial Infection Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nosocomial Infection Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nosocomial Infection Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nosocomial Infection Treatment Market Report

Report Metric Details
Report Name Nosocomial Infection Treatment Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Antibacterial Treatment
  • Antiviral Treatment
  • Antifungal Treatment
Segment by Application
  • Ventilator Associated Pneumonia
  • Urinary Tract Infection
  • Blood Stream Infection
  • Surgical Site Infection
  • Gastrointestinal Infection
  • MRSA
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Bayer, Becton, Dickinson and Company, Belimed, BioMerieux, Cantel, Cepheid, Getinge Group, Kimberly-Clark Corp., Merck & Co, Nordion, Pfizer, Roche, Sakura Seiki, BioMérieux, Steris, Johnson & Johnson, Sterigenics International, Inc., Halyard Health, Inc., Advanced Sterilization Products, Matachana Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nosocomial Infection Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nosocomial Infection Treatment Market report?

Ans: The main players in the Nosocomial Infection Treatment Market are Abbott, Bayer, Becton, Dickinson and Company, Belimed, BioMerieux, Cantel, Cepheid, Getinge Group, Kimberly-Clark Corp., Merck & Co, Nordion, Pfizer, Roche, Sakura Seiki, BioMérieux, Steris, Johnson & Johnson, Sterigenics International, Inc., Halyard Health, Inc., Advanced Sterilization Products, Matachana Group

What are the Application segmentation covered in the Nosocomial Infection Treatment Market report?

Ans: The Applications covered in the Nosocomial Infection Treatment Market report are Ventilator Associated Pneumonia, Urinary Tract Infection, Blood Stream Infection, Surgical Site Infection, Gastrointestinal Infection, MRSA

What are the Type segmentation covered in the Nosocomial Infection Treatment Market report?

Ans: The Types covered in the Nosocomial Infection Treatment Market report are Antibacterial Treatment, Antiviral Treatment, Antifungal Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nosocomial Infection Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterial Treatment
1.2.3 Antiviral Treatment
1.2.4 Antifungal Treatment
1.3 Market by Application
1.3.1 Global Nosocomial Infection Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Ventilator Associated Pneumonia
1.3.3 Urinary Tract Infection
1.3.4 Blood Stream Infection
1.3.5 Surgical Site Infection
1.3.6 Gastrointestinal Infection
1.3.7 MRSA
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nosocomial Infection Treatment Market Perspective (2019-2030)
2.2 Nosocomial Infection Treatment Growth Trends by Region
2.2.1 Global Nosocomial Infection Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nosocomial Infection Treatment Historic Market Size by Region (2019-2024)
2.2.3 Nosocomial Infection Treatment Forecasted Market Size by Region (2025-2030)
2.3 Nosocomial Infection Treatment Market Dynamics
2.3.1 Nosocomial Infection Treatment Industry Trends
2.3.2 Nosocomial Infection Treatment Market Drivers
2.3.3 Nosocomial Infection Treatment Market Challenges
2.3.4 Nosocomial Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nosocomial Infection Treatment Players by Revenue
3.1.1 Global Top Nosocomial Infection Treatment Players by Revenue (2019-2024)
3.1.2 Global Nosocomial Infection Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Nosocomial Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nosocomial Infection Treatment Revenue
3.4 Global Nosocomial Infection Treatment Market Concentration Ratio
3.4.1 Global Nosocomial Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nosocomial Infection Treatment Revenue in 2023
3.5 Nosocomial Infection Treatment Key Players Head office and Area Served
3.6 Key Players Nosocomial Infection Treatment Product Solution and Service
3.7 Date of Enter into Nosocomial Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nosocomial Infection Treatment Breakdown Data by Type
4.1 Global Nosocomial Infection Treatment Historic Market Size by Type (2019-2024)
4.2 Global Nosocomial Infection Treatment Forecasted Market Size by Type (2025-2030)
5 Nosocomial Infection Treatment Breakdown Data by Application
5.1 Global Nosocomial Infection Treatment Historic Market Size by Application (2019-2024)
5.2 Global Nosocomial Infection Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nosocomial Infection Treatment Market Size (2019-2030)
6.2 North America Nosocomial Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nosocomial Infection Treatment Market Size by Country (2019-2024)
6.4 North America Nosocomial Infection Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nosocomial Infection Treatment Market Size (2019-2030)
7.2 Europe Nosocomial Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nosocomial Infection Treatment Market Size by Country (2019-2024)
7.4 Europe Nosocomial Infection Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nosocomial Infection Treatment Market Size (2019-2030)
8.2 Asia-Pacific Nosocomial Infection Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nosocomial Infection Treatment Market Size (2019-2030)
9.2 Latin America Nosocomial Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nosocomial Infection Treatment Market Size by Country (2019-2024)
9.4 Latin America Nosocomial Infection Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nosocomial Infection Treatment Market Size (2019-2030)
10.2 Middle East & Africa Nosocomial Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Nosocomial Infection Treatment Introduction
11.1.4 Abbott Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Nosocomial Infection Treatment Introduction
11.2.4 Bayer Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Detail
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Nosocomial Infection Treatment Introduction
11.3.4 Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 Belimed
11.4.1 Belimed Company Detail
11.4.2 Belimed Business Overview
11.4.3 Belimed Nosocomial Infection Treatment Introduction
11.4.4 Belimed Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.4.5 Belimed Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Detail
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Nosocomial Infection Treatment Introduction
11.5.4 BioMerieux Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.5.5 BioMerieux Recent Development
11.6 Cantel
11.6.1 Cantel Company Detail
11.6.2 Cantel Business Overview
11.6.3 Cantel Nosocomial Infection Treatment Introduction
11.6.4 Cantel Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.6.5 Cantel Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Detail
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Nosocomial Infection Treatment Introduction
11.7.4 Cepheid Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.7.5 Cepheid Recent Development
11.8 Getinge Group
11.8.1 Getinge Group Company Detail
11.8.2 Getinge Group Business Overview
11.8.3 Getinge Group Nosocomial Infection Treatment Introduction
11.8.4 Getinge Group Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.8.5 Getinge Group Recent Development
11.9 Kimberly-Clark Corp.
11.9.1 Kimberly-Clark Corp. Company Detail
11.9.2 Kimberly-Clark Corp. Business Overview
11.9.3 Kimberly-Clark Corp. Nosocomial Infection Treatment Introduction
11.9.4 Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.9.5 Kimberly-Clark Corp. Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Detail
11.10.2 Merck & Co Business Overview
11.10.3 Merck & Co Nosocomial Infection Treatment Introduction
11.10.4 Merck & Co Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.10.5 Merck & Co Recent Development
11.11 Nordion
11.11.1 Nordion Company Detail
11.11.2 Nordion Business Overview
11.11.3 Nordion Nosocomial Infection Treatment Introduction
11.11.4 Nordion Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.11.5 Nordion Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Nosocomial Infection Treatment Introduction
11.12.4 Pfizer Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.12.5 Pfizer Recent Development
11.13 Roche
11.13.1 Roche Company Detail
11.13.2 Roche Business Overview
11.13.3 Roche Nosocomial Infection Treatment Introduction
11.13.4 Roche Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.13.5 Roche Recent Development
11.14 Sakura Seiki
11.14.1 Sakura Seiki Company Detail
11.14.2 Sakura Seiki Business Overview
11.14.3 Sakura Seiki Nosocomial Infection Treatment Introduction
11.14.4 Sakura Seiki Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.14.5 Sakura Seiki Recent Development
11.15 BioMérieux
11.15.1 BioMérieux Company Detail
11.15.2 BioMérieux Business Overview
11.15.3 BioMérieux Nosocomial Infection Treatment Introduction
11.15.4 BioMérieux Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.15.5 BioMérieux Recent Development
11.16 Steris
11.16.1 Steris Company Detail
11.16.2 Steris Business Overview
11.16.3 Steris Nosocomial Infection Treatment Introduction
11.16.4 Steris Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.16.5 Steris Recent Development
11.17 Johnson & Johnson
11.17.1 Johnson & Johnson Company Detail
11.17.2 Johnson & Johnson Business Overview
11.17.3 Johnson & Johnson Nosocomial Infection Treatment Introduction
11.17.4 Johnson & Johnson Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.17.5 Johnson & Johnson Recent Development
11.18 Sterigenics International, Inc.
11.18.1 Sterigenics International, Inc. Company Detail
11.18.2 Sterigenics International, Inc. Business Overview
11.18.3 Sterigenics International, Inc. Nosocomial Infection Treatment Introduction
11.18.4 Sterigenics International, Inc. Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.18.5 Sterigenics International, Inc. Recent Development
11.19 Halyard Health, Inc.
11.19.1 Halyard Health, Inc. Company Detail
11.19.2 Halyard Health, Inc. Business Overview
11.19.3 Halyard Health, Inc. Nosocomial Infection Treatment Introduction
11.19.4 Halyard Health, Inc. Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.19.5 Halyard Health, Inc. Recent Development
11.20 Advanced Sterilization Products
11.20.1 Advanced Sterilization Products Company Detail
11.20.2 Advanced Sterilization Products Business Overview
11.20.3 Advanced Sterilization Products Nosocomial Infection Treatment Introduction
11.20.4 Advanced Sterilization Products Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.20.5 Advanced Sterilization Products Recent Development
11.21 Matachana Group
11.21.1 Matachana Group Company Detail
11.21.2 Matachana Group Business Overview
11.21.3 Matachana Group Nosocomial Infection Treatment Introduction
11.21.4 Matachana Group Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.21.5 Matachana Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Abbott
Bayer
Becton Dickinson and Company
BELIMED
Biomerieux
Cantel
Cepheid Inc
Getinge Group
Kimberly Clark Corp
Merck
Nordion
Pfizer Inc
Roche
Sakura Seiki
bioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc
Advanced Sterilization Products
Matachana group
List of Tables
    Table 1. Global Nosocomial Infection Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Antibacterial Treatment
    Table 3. Key Players of Antiviral Treatment
    Table 4. Key Players of Antifungal Treatment
    Table 5. Global Nosocomial Infection Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Nosocomial Infection Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Nosocomial Infection Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Nosocomial Infection Treatment Market Share by Region (2019-2024)
    Table 9. Global Nosocomial Infection Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Nosocomial Infection Treatment Market Share by Region (2025-2030)
    Table 11. Nosocomial Infection Treatment Market Trends
    Table 12. Nosocomial Infection Treatment Market Drivers
    Table 13. Nosocomial Infection Treatment Market Challenges
    Table 14. Nosocomial Infection Treatment Market Restraints
    Table 15. Global Nosocomial Infection Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Nosocomial Infection Treatment Market Share by Players (2019-2024)
    Table 17. Global Top Nosocomial Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nosocomial Infection Treatment as of 2023)
    Table 18. Ranking of Global Top Nosocomial Infection Treatment Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Nosocomial Infection Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Nosocomial Infection Treatment Product Solution and Service
    Table 22. Date of Enter into Nosocomial Infection Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Nosocomial Infection Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Nosocomial Infection Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Nosocomial Infection Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Nosocomial Infection Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Nosocomial Infection Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Nosocomial Infection Treatment Revenue Market Share by Application (2019-2024)
    Table 30. Global Nosocomial Infection Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Nosocomial Infection Treatment Revenue Market Share by Application (2025-2030)
    Table 32. North America Nosocomial Infection Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Nosocomial Infection Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Nosocomial Infection Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Nosocomial Infection Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Nosocomial Infection Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Nosocomial Infection Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Nosocomial Infection Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Nosocomial Infection Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Nosocomial Infection Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Nosocomial Infection Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Nosocomial Infection Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Abbott Company Detail
    Table 48. Abbott Business Overview
    Table 49. Abbott Nosocomial Infection Treatment Product
    Table 50. Abbott Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 51. Abbott Recent Development
    Table 52. Bayer Company Detail
    Table 53. Bayer Business Overview
    Table 54. Bayer Nosocomial Infection Treatment Product
    Table 55. Bayer Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 56. Bayer Recent Development
    Table 57. Becton, Dickinson and Company Company Detail
    Table 58. Becton, Dickinson and Company Business Overview
    Table 59. Becton, Dickinson and Company Nosocomial Infection Treatment Product
    Table 60. Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 61. Becton, Dickinson and Company Recent Development
    Table 62. Belimed Company Detail
    Table 63. Belimed Business Overview
    Table 64. Belimed Nosocomial Infection Treatment Product
    Table 65. Belimed Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 66. Belimed Recent Development
    Table 67. BioMerieux Company Detail
    Table 68. BioMerieux Business Overview
    Table 69. BioMerieux Nosocomial Infection Treatment Product
    Table 70. BioMerieux Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 71. BioMerieux Recent Development
    Table 72. Cantel Company Detail
    Table 73. Cantel Business Overview
    Table 74. Cantel Nosocomial Infection Treatment Product
    Table 75. Cantel Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 76. Cantel Recent Development
    Table 77. Cepheid Company Detail
    Table 78. Cepheid Business Overview
    Table 79. Cepheid Nosocomial Infection Treatment Product
    Table 80. Cepheid Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 81. Cepheid Recent Development
    Table 82. Getinge Group Company Detail
    Table 83. Getinge Group Business Overview
    Table 84. Getinge Group Nosocomial Infection Treatment Product
    Table 85. Getinge Group Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 86. Getinge Group Recent Development
    Table 87. Kimberly-Clark Corp. Company Detail
    Table 88. Kimberly-Clark Corp. Business Overview
    Table 89. Kimberly-Clark Corp. Nosocomial Infection Treatment Product
    Table 90. Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 91. Kimberly-Clark Corp. Recent Development
    Table 92. Merck & Co Company Detail
    Table 93. Merck & Co Business Overview
    Table 94. Merck & Co Nosocomial Infection Treatment Product
    Table 95. Merck & Co Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 96. Merck & Co Recent Development
    Table 97. Nordion Company Detail
    Table 98. Nordion Business Overview
    Table 99. Nordion Nosocomial Infection Treatment Product
    Table 100. Nordion Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 101. Nordion Recent Development
    Table 102. Pfizer Company Detail
    Table 103. Pfizer Business Overview
    Table 104. Pfizer Nosocomial Infection Treatment Product
    Table 105. Pfizer Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 106. Pfizer Recent Development
    Table 107. Roche Company Detail
    Table 108. Roche Business Overview
    Table 109. Roche Nosocomial Infection Treatment Product
    Table 110. Roche Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 111. Roche Recent Development
    Table 112. Sakura Seiki Company Detail
    Table 113. Sakura Seiki Business Overview
    Table 114. Sakura Seiki Nosocomial Infection Treatment Product
    Table 115. Sakura Seiki Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 116. Sakura Seiki Recent Development
    Table 117. BioMérieux Company Detail
    Table 118. BioMérieux Business Overview
    Table 119. BioMérieux Nosocomial Infection Treatment Product
    Table 120. BioMérieux Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 121. BioMérieux Recent Development
    Table 122. Steris Company Detail
    Table 123. Steris Business Overview
    Table 124. Steris Nosocomial Infection Treatment Product
    Table 125. Steris Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 126. Steris Recent Development
    Table 127. Johnson & Johnson Company Detail
    Table 128. Johnson & Johnson Business Overview
    Table 129. Johnson & Johnson Nosocomial Infection Treatment Product
    Table 130. Johnson & Johnson Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 131. Johnson & Johnson Recent Development
    Table 132. Sterigenics International, Inc. Company Detail
    Table 133. Sterigenics International, Inc. Business Overview
    Table 134. Sterigenics International, Inc. Nosocomial Infection Treatment Product
    Table 135. Sterigenics International, Inc. Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 136. Sterigenics International, Inc. Recent Development
    Table 137. Halyard Health, Inc. Company Detail
    Table 138. Halyard Health, Inc. Business Overview
    Table 139. Halyard Health, Inc. Nosocomial Infection Treatment Product
    Table 140. Halyard Health, Inc. Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 141. Halyard Health, Inc. Recent Development
    Table 142. Advanced Sterilization Products Company Detail
    Table 143. Advanced Sterilization Products Business Overview
    Table 144. Advanced Sterilization Products Nosocomial Infection Treatment Product
    Table 145. Advanced Sterilization Products Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 146. Advanced Sterilization Products Recent Development
    Table 147. Matachana Group Company Detail
    Table 148. Matachana Group Business Overview
    Table 149. Matachana Group Nosocomial Infection Treatment Product
    Table 150. Matachana Group Revenue in Nosocomial Infection Treatment Business (2019-2024) & (US$ Million)
    Table 151. Matachana Group Recent Development
    Table 152. Research Programs/Design for This Report
    Table 153. Key Data Information from Secondary Sources
    Table 154. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nosocomial Infection Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Nosocomial Infection Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Antibacterial Treatment Features
    Figure 4. Antiviral Treatment Features
    Figure 5. Antifungal Treatment Features
    Figure 6. Global Nosocomial Infection Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Nosocomial Infection Treatment Market Share by Application: 2023 VS 2030
    Figure 8. Ventilator Associated Pneumonia Case Studies
    Figure 9. Urinary Tract Infection Case Studies
    Figure 10. Blood Stream Infection Case Studies
    Figure 11. Surgical Site Infection Case Studies
    Figure 12. Gastrointestinal Infection Case Studies
    Figure 13. MRSA Case Studies
    Figure 14. Nosocomial Infection Treatment Report Years Considered
    Figure 15. Global Nosocomial Infection Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Nosocomial Infection Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Nosocomial Infection Treatment Market Share by Region: 2023 VS 2030
    Figure 18. Global Nosocomial Infection Treatment Market Share by Players in 2023
    Figure 19. Global Top Nosocomial Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nosocomial Infection Treatment as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Nosocomial Infection Treatment Revenue in 2023
    Figure 21. North America Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Nosocomial Infection Treatment Market Share by Country (2019-2030)
    Figure 23. United States Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Nosocomial Infection Treatment Market Share by Country (2019-2030)
    Figure 27. Germany Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Nosocomial Infection Treatment Market Share by Region (2019-2030)
    Figure 35. China Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Japan Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. South Korea Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Southeast Asia Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. India Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Australia Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Nosocomial Infection Treatment Market Share by Country (2019-2030)
    Figure 43. Mexico Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Brazil Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Nosocomial Infection Treatment Market Share by Country (2019-2030)
    Figure 47. Turkey Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Nosocomial Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Abbott Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 50. Bayer Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 51. Becton, Dickinson and Company Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 52. Belimed Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 53. BioMerieux Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 54. Cantel Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 55. Cepheid Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 56. Getinge Group Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 57. Kimberly-Clark Corp. Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 58. Merck & Co Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 59. Nordion Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 60. Pfizer Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 61. Roche Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 62. Sakura Seiki Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 63. BioMérieux Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 64. Steris Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 65. Johnson & Johnson Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 66. Sterigenics International, Inc. Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 67. Halyard Health, Inc. Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 68. Advanced Sterilization Products Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 69. Matachana Group Revenue Growth Rate in Nosocomial Infection Treatment Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26K6048
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20L6129
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4F6384
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16N6009
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions